Search results
Results from the WOW.Com Content Network
The New York City Economic Development Corporation's Early Stage Life Sciences Funding Initiative and venture capital partners, including Celgene, General Electric Ventures, and Eli Lilly, committed a minimum of US$100 million to help launch 15 to 20 ventures in life sciences and biotechnology in 2014, [6] and in January 2018, the City of New ...
The R&D group at teva api consists of a team of over 760 top scientists located in 7 development centers worldwide: A large center in Israel (synthetic products and peptides), a large center in Hungary (fermentation and semi-synthetic products), and a facility in India and additional sites in Italy, Croatia, Mexico and the Czech Republic (development of high potency API). teva api's R&D ...
Amarin Corporation plc (formerly Ethical Holdings plc) was originally incorporated in England as a private limited company on March 1, 1989, and later re-registered as a public company on March 19, 1993. [9] In 2002, the company suffered losses worth $37 million; 2003 losses exceeded $19 million. [10] As of 2005, it was developing neurology drugs.
EyePoint Pharmaceuticals Inc. (formerly pSivida Corporation) is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery. pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency (DERA, now QinetiQ).
Samuel D. Waksal (born September 8, 1947) is the founder and former CEO of the biopharmaceutical company ImClone Systems. He is also the founder of Kadmon Pharmaceuticals, which was financed with private capital and commenced operations in New York City in 2010. [1] At ImClone, Waksal led the company to develop the cancer drug Erbitux (cetuximab).
In 1947 the business was resurrected, and registered in the State of New York under the name the Stiefel Medicinal Soap Company, Inc., initially operating from a former creamery in Oak Hill, New York. As the product line grew and diversified beyond medicinal soaps, the company was renamed Stiefel Laboratories, Inc. [7]
Register of Entrepreneurs (Rejestr przedsiębiorców) — the company register for entities other than natural persons which hold an obligatory status of entrepreneurs: trade partnerships: either entities with legal capacity but lacking juridical personality (registered partnerships, limited partnerships, limited joint-stock partnerships ...
Repligen Corporation is an American company devoted to the development and production of materials used in the manufacture of biological drugs. 2014 The company is based in Waltham, Massachusetts, 2014 and was incorporated in Delaware in 1981. [1] A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. [2]